-
Abel K, Compton L, Rourke T, et al. 2003. Simian-Human immunodeficiency virus SHIV89.6-induced pro-tection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. J Virol, 77 (5): 3099-3118.
doi: 10.1128/JVI.77.5.3099-3118.2003
-
Cong Z, Tu X M, Jiang H, et al.2005. Application of PCR techniques in detection of simian immunodeficiency virus (SIV) in monkey infection models.Acta Lab Anim Sci Sin, 13 (2): 84-87. (in Chinese).
-
Estaquier J, Monceaux V, Cumont M C, et al. 2000. Early changes in peripheral blood T cells during primary infection of rhesus macaques with a pathogenic SIV. J Med Primatol, 29 (3-4): 127-135.
-
Girard M, Mahoney J, Wei Q, et al. 1998. Genital infection of female chimpanzees with human immun-odeficiency virus type 1. AIDS Res Hum Retrovirused, 14 (15): 1357-1367.
doi: 10.1089/aid.1998.14.1357
-
Guo W Z, Lu Y Z, Wu X X, et al. 2005. Experimental study on ATA prescription in treating monkey with chronic infection of simian immunodeficiency virus. J Guangzhou Univ Tradit Chin Medi, 22 (4): 296-298 (in Chinese).
-
Kuwata T, Kodama M, Sato A, et al. 2007. Contribution of monocytes to viral replication in macaques during acute infection with simian immunodeficiency virus. AIDS Res Hum Retroviruses, 23 (3): 372-380.
doi: 10.1089/aid.2006.0208
-
Li M H, He Z Y, Zheng Y T. 2005. The scapegoat of human AIDS research: non-human primate models. Chin J Nat, 27 (4): 208-212. (in Chinese).
-
Li M H, Zhang G H, Sun T, et al. 2007. The value of nonhuman primate animal models in anti-HIV drug studies.Chin J New Drug, 16: (16): 1237-1242. (in Chinese).
-
Ling B, Veazey R S, Penedo C, et al. 2002. Longitudinal follow up of SIVmac phthogenesis in rhesus macaques of Chinese origin: emergence of B cell lymphoma. J Med Primatol, 31: 154-163.
doi: 10.1034/j.1600-0684.2002.02001.x
-
Lu Y Z, Wu X X, Tu X M, et al. 1994. The establishment of SIV-infected macaque models [J]. Acta Lab Anim Sci Sin, 2 (2): 94-101. (in Chinese).
-
McDermott A B, Mitchen J, Piaskowski S, et al. 2004. Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates. J Virol, 78 (6): 3140-3144.
doi: 10.1128/JVI.78.6.3140-3144.2004
-
Metzner K J, Moretto W J, Donahoe S M, et al.2005. Evaluation of CD8+ T-cell and antibody responses follo-wing transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.J Gen Virol, 86: 3375-3384.
doi: 10.1099/vir.0.81206-0
-
Miller C J, Abel K. 2005. Immune mechanisms associated with protection from vaginal SIV challenge in rhesus monkeys infected with virulence-attenuated SHIV89.6. J Med Primatol, 34 (5-6): 271-281.
doi: 10.1111/jmp.2005.34.issue-5-6
-
Muller M C, Barre-Sinoussi F. 2003. SIVagm: genetic and biological features associated with replication. Front Biosci, 8: 1170-1185.
doi: 10.2741/1130
-
Yamamoto H, Kawada M, Tsukamoto T, et al.2007. Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques. J Gen Virol, 88: 652-659.
doi: 10.1099/vir.0.82469-0